United States · FDA National Drug Code directory
Lurasidone hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-966_5e755270-5e9a-4208-b52b-3eaeaf652902
- Product NDC
- 68382-966
- Form
- TABLET, COATED
- Composition / generic term
- Lurasidone hydrochloride
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230201
- Source listing expiry
- 20271231
Source-listed ingredients
- LURASIDONE HYDROCHLORIDE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, COATED in 1 BOTTLE (68382-966-01) · 68382-966-01
- 500 TABLET, COATED in 1 BOTTLE (68382-966-05) · 68382-966-05
- 30 TABLET, COATED in 1 BOTTLE (68382-966-06) · 68382-966-06
- 90 TABLET, COATED in 1 BOTTLE (68382-966-16) · 68382-966-16
- 100 BLISTER PACK in 1 CARTON (68382-966-77) / 1 TABLET, COATED in 1 BLISTER PACK (68382-966-30) · 68382-966-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →